Literature DB >> 26384083

Prolonged Complete Response in a Pediatric Patient With Primary Peripheral T-Cell Lymphoma of the Central Nervous System.

Haneen Shalabi1, Anne Angiolillo1, Gilbert Vezina2, James L Rubenstein3, Stefania Pittaluga4, Mark Raffeld4, Leigh Marcus5.   

Abstract

We describe a child with a 2-week history of progressive headaches, blurry vision, and intermittent vomiting. Magnetic resonance imaging (MRI) of the brain showed a deep left hemispheric lesion with extension into the corpus callosum. Histology and immunophenotyping of the lesion was consistent with peripheral T-cell lymphoma, not otherwise specified. Chemotherapy was initiated and a complete remission was achieved. This case illustrates that a chemotherapeutic regimen used in adults with central nervous system (CNS) lymphoma can achieve durable remissions in pediatric patients with peripheral T-cell lymphoma, not otherwise specified of the CNS.

Entities:  

Keywords:  CNS tumors; NHL; therapy

Mesh:

Year:  2015        PMID: 26384083      PMCID: PMC4942274          DOI: 10.3109/08880018.2015.1074325

Source DB:  PubMed          Journal:  Pediatr Hematol Oncol        ISSN: 0888-0018            Impact factor:   1.969


  17 in total

1.  A case series of pediatric primary central nervous system lymphoma: favorable outcome without cranial irradiation.

Authors:  Oussama Abla; John T Sandlund; Lillian Sung; Penelope Brock; Rob Corbett; Ivan Kirov; Timothy C Griffin; Susan Blaser; Sheila Weitzman
Journal:  Pediatr Blood Cancer       Date:  2006-12       Impact factor: 3.167

2.  First case report of a peripheral T-cell lymphoma, not otherwise specified, of the central nervous system in a child.

Authors:  Maria Lueth; Harald Stein; Birgit Spors; Guenter Henze; Pablo Hernáiz Driever
Journal:  J Pediatr Hematol Oncol       Date:  2012-03       Impact factor: 1.289

3.  Primary central nervous system peripheral T-cell lymphoma in a child.

Authors:  Gabriela Gualco; Sheila Wludarski; Luciana Hayashi-Silva; Plinio Medeiros Filho; Geni Veras; Carlos Eduardo Bacchi
Journal:  Fetal Pediatr Pathol       Date:  2010       Impact factor: 0.958

4.  Primary central nervous system lymphoma in children and adolescents: low relapse rate after treatment according to Non-Hodgkin-Lymphoma Berlin-Frankfurt-Münster protocols for systemic lymphoma.

Authors:  Heike Thorer; Martin Zimmermann; Olga Makarova; Ilske Oschlies; Wolfram Klapper; Peter Lang; Arend von Stackelberg; Gudrun Fleischhack; Jennifer Worch; Heribert Juergens; Wilhelm Woessmann; Alfred Reiter; Birgit Burkhardt
Journal:  Haematologica       Date:  2014-08-08       Impact factor: 9.941

5.  Type II enteropathy-associated T-cell lymphoma: a distinct aggressive lymphoma with frequent γδ T-cell receptor expression.

Authors:  John K C Chan; Alexander C L Chan; Wah Cheuk; Suk-King Wan; Wai-Ki Lee; Yun-Hoi Lui; Wai-Kong Chan
Journal:  Am J Surg Pathol       Date:  2011-10       Impact factor: 6.394

6.  Primary CNS lymphoma of T-cell origin: a descriptive analysis from the international primary CNS lymphoma collaborative group.

Authors:  Tamara N Shenkier; Jean-Yves Blay; Brian Patrick O'Neill; Philip Poortmans; Eckhard Thiel; Kristoph Jahnke; Lauren E Abrey; Edward Neuwelt; Richard Tsang; Tracy Batchelor; Nancy Harris; Andrés J M Ferreri; Maurilio Ponzoni; Peter O'Brien; James Rubenstein; Joseph M Connors
Journal:  J Clin Oncol       Date:  2005-04-01       Impact factor: 44.544

7.  New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).

Authors:  E A Eisenhauer; P Therasse; J Bogaerts; L H Schwartz; D Sargent; R Ford; J Dancey; S Arbuck; S Gwyther; M Mooney; L Rubinstein; L Shankar; L Dodd; R Kaplan; D Lacombe; J Verweij
Journal:  Eur J Cancer       Date:  2009-01       Impact factor: 9.162

8.  Peripheral T-cell lymphoma in childhood: population-based experience in the United Kingdom over 20 years.

Authors:  Rachael Windsor; Charles Stiller; David Webb
Journal:  Pediatr Blood Cancer       Date:  2008-04       Impact factor: 3.167

9.  How I treat CNS lymphomas.

Authors:  James L Rubenstein; Neel K Gupta; Gabriel N Mannis; Amanda K Lamarre; Patrick Treseler
Journal:  Blood       Date:  2013-08-20       Impact factor: 22.113

10.  Intensive chemotherapy and immunotherapy in patients with newly diagnosed primary CNS lymphoma: CALGB 50202 (Alliance 50202).

Authors:  James L Rubenstein; Eric D Hsi; Jeffrey L Johnson; Sin-Ho Jung; Megan O Nakashima; Barbara Grant; Bruce D Cheson; Lawrence D Kaplan
Journal:  J Clin Oncol       Date:  2013-04-08       Impact factor: 44.544

View more
  1 in total

1.  Primary peripheral T-cell central nervous system lymphoma.

Authors:  Cylaina E Bird; Jeffrey I Traylor; Jenna Thomas; James P Caruso; Benjamin Kafka; Flavia Rosado; Kyle M Blackburn; Kimmo J Hatanpaa; Kalil G Abdullah
Journal:  Surg Neurol Int       Date:  2021-09-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.